Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Oral Synthetic CBD in Healthy Occasional Cannabis Users
NCT05407285Phase 2Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jul 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, sponsored by Centre hospitalier de l’Université de Montréal. Started Jul 2022; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT05407285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05407285.